Producenci
Ryanodine receptor 1 (RyR1) (3614-3643); Calmodulin Binding Peptide (CaMBP)
S-Trityl-Mercaptoacetic acid
S-Trityl-Mercaptoacetic acid
S3 Fragment, ADF/cofilin, LIMK1 substrate
S6 Kinase Substrate (229-239)
S6 Kinase Substrate (229-239)
S6 Kinase Substrate (229-239), Amide, Biotinalyted
SAMS Peptide [HMRSAMSGLHLVKRR-NH2]
SAMs peptide, FAM labeled
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 - 0.5 mg
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - 0.5 mg
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - 0.5 mg
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - 0.5 mg
SARS-CoV Peptide Antigen I - 1mg NET peptide
SARS-CoV Peptide Antigen Negative control - 1mg NET peptide
SARS-CoV Peptide Antigen Positive control - 1mg NET peptide
SARS-CoV T-cell Peptide Antigens Set - 0.25 mg Net
SARS-CoV-2 Spike receptor binding domain, RBD (319-335) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (319-335) -Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (348-357) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (348-357)- Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - 0.5 mg
SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - Lys(Biotin-LC) - 0.1 mg
SARS-CoV-2 Spike receptor binding domain, RBD (513-520) - 0.5 mg